129 related articles for article (PubMed ID: 15885361)
1. A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid.
Castro RE; Solá S; Ma X; Ramalho RM; Kren BT; Steer CJ; Rodrigues CM
J Hepatol; 2005 Jun; 42(6):897-906. PubMed ID: 15885361
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes.
Castro RE; Amaral JD; Solá S; Kren BT; Steer CJ; Rodrigues CM
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G327-34. PubMed ID: 17431217
[TBL] [Abstract][Full Text] [Related]
3. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM
Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
[TBL] [Abstract][Full Text] [Related]
5. Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-beta1-induced apoptosis in rat hepatocytes.
Solá S; Amaral JD; Castro RE; Ramalho RM; Borralho PM; Kren BT; Tanaka H; Steer CJ; Rodrigues CM
Hepatology; 2005 Oct; 42(4):925-34. PubMed ID: 16175607
[TBL] [Abstract][Full Text] [Related]
6. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
7. [Effects of bile acid preparations on DNA biosynthesis, apoptosis, and necrosis in hepatocytes in vitro].
Danchenko EO
Vopr Med Khim; 2001; 47(2):236-42. PubMed ID: 11450444
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid.
Chen L; Borozan I; Milkiewicz P; Sun J; Meng X; Coltescu C; Edwards AM; Ostrowski MA; Guindi M; Heathcote EJ; McGilvray ID
Liver Int; 2008 Aug; 28(7):997-1010. PubMed ID: 18422935
[TBL] [Abstract][Full Text] [Related]
9. Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.
Arenas F; Hervias I; Uriz M; Joplin R; Prieto J; Medina JF
J Clin Invest; 2008 Feb; 118(2):695-709. PubMed ID: 18188457
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes.
Azzaroli F; Mehal W; Soroka CJ; Wang L; Lee J; Crispe IN; Boyer JL
Hepatology; 2002 Jul; 36(1):49-54. PubMed ID: 12085348
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
Alpini G; Baiocchi L; Glaser S; Ueno Y; Marzioni M; Francis H; Phinizy JL; Angelico M; Lesage G
Hepatology; 2002 May; 35(5):1041-52. PubMed ID: 11981754
[TBL] [Abstract][Full Text] [Related]
12. The effect of ursodeoxycholic acid on glycochenodeoxycholic acid-induced apoptosis in rat hepatocytes.
Utanohara S; Tsuji M; Momma S; Morio Y; Oguchi K
Toxicology; 2005 Oct; 214(1-2):77-86. PubMed ID: 16023280
[TBL] [Abstract][Full Text] [Related]
13. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver.
Wimmer R; Hohenester S; Pusl T; Denk GU; Rust C; Beuers U
Gut; 2008 Oct; 57(10):1448-54. PubMed ID: 18583398
[TBL] [Abstract][Full Text] [Related]
14. Modulation of steady-state messenger RNA levels in the regenerating rat liver with bile acid feeding.
Kren BT; Rodrigues CM; Setchell KD; Steer CJ
Liver Transpl; 2001 Apr; 7(4):321-34. PubMed ID: 11303292
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes.
Sola S; Ma X; Castro RE; Kren BT; Steer CJ; Rodrigues CM
J Biol Chem; 2003 Dec; 278(49):48831-8. PubMed ID: 14514686
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid enhances glucocorticoid-induced tyrosine aminotransferase-gene expression in cultured rat hepatocytes.
Mitsuyoshi H; Nakashima T; Inaba K; Ishikawa H; Nakajima Y; Sakamoto Y; Matsumoto M; Okanoue T; Kashima K
Biochem Biophys Res Commun; 1997 Nov; 240(3):732-6. PubMed ID: 9398635
[TBL] [Abstract][Full Text] [Related]
17. [Modulation by tauroursodeoxycholic acid of proliferation of the rat ischemic liver hepatocytes].
Danchenko EO
Vopr Med Khim; 2001; 47(4):405-10. PubMed ID: 11693028
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
19. Chenodeoxycholic acid and taurochenodexycholic acid induce anti-apoptotic cIAP-1 expression in human hepatocytes.
Hirano F; Haneda M; Makino I
J Gastroenterol Hepatol; 2006 Dec; 21(12):1807-13. PubMed ID: 17074018
[TBL] [Abstract][Full Text] [Related]
20. The protective effect of ursodeoxycholic acid in alloxan-induced diabetes.
Lukivskaya O; Lis R; Egorov A; Naruta E; Tauschel HD; Buko VU
Cell Biochem Funct; 2004; 22(2):97-103. PubMed ID: 15027098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
